Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

Tonix Pharmaceuticals is also enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

Contact

Contact

Thank you for your interest in learning more about Tonix. We look forward to hearing from you.

Tonix Pharmaceuticals Holding Corp.

509 Madison Avenue
Suite 1608
New York, NY 10022

(212) 980-9155 (phone)
(212) 923-5700 (fax)
investor.relations@tonixpharma.com

Tonix Canada Office
1176 rue Bishop - Office 317, Montreal, QC, H3G 2E3
514-657-2335

Tonix Ireland Office
No. 56 Fitzwilliam Square North,
Dublin 2, D02 X224, Ireland
353-1- 6532146

Tonix La Jolla, CA Office
4225 Executive Square
Suite 250
La Jolla, CA 92037
858-333-5635